3Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation, 2000,101:676-681.
4Jiang ZY, Lin YW, Clemont A, et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker rats. J Clin Invest, 1999,104:447-457.
5Laws A, Reaven GM. Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E (ed). Clinical endocrinology and metabolism. London:Bailliere Tindall, 1993.1063-1078.
6Laakso M, Edlelman SV, Brechtel G, et al. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest, 1990,85:1844-1852.
7Laakso M, Edelman SV, Brechtel G, et al. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes, 1992,41:1076-1083.
8Steinberg HO, Brechtel G, Johnson A, et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest, 1994,94:1172-1179.
9Scherrer U, Randin D, Vollenweinder P, et al. Nitric oxide release accounts for insulin′s vascular effects in humans. J Clin Invest, 1994,94:2511-2515.
10Steinberg HO, Chaker H, Leamin R, et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest, 1996,97:2601-2610.
